West Nile virus (WNV) is a member of the Flavivirus genus (Flaviviridae), which includes other important arboviruses, such as dengue, yellow fever, Japanese encephalitis, and St. Louis encephalitis viruses 1 . West Nile virus is maintained through a natural cycle involving mosquitoes and birds. The virus also infects humans, horses, and other animals. In humans, WNV can cause illnesses ranging from mild fever to central nervous system infections, including flaccid paralysis and lethal encephalitis. For this reason, WNV is considered as an important public health issue 2 . Historically, outbreaks of WNV have occurred in the Middle East, Europe, and Africa. In 1999, WNV was introduced into North America 3 , and over the last 10 years, it has spread throughout the United States, as well as Canada, Mexico, the Caribbean, and Central and South America [4] [5] [6] . Therefore, there is an imminent risk of the WNV introduction in Brazil, and consequently, diagnostic tools are extremely important to perform surveillance and prevent future outbreaks.
West Nile virus is a single-stranded, positive-polarity enveloped ribonucleic acid (RNA) virus with a genome of 11 kilobases, which encodes 10 proteins, three structural and seven nonstructural. The structural proteins include capsid (C), premembrane (prM), and envelope (E) protein. E protein functions in receptor binding, membrane fusion, and viral assembly, and prM assists in proper folding and function of the E protein 7 . Crystallographic studies reveal that the E protein of flaviviruses folds into three domains: DI, DII, and DIII. In particular, DIII of E is the putative receptor-binding domain, an important target for neutralizing antibodies and in vivo protection 8, 9 . Some authors have suggested that DIII from dengue virus types 1 to 4 (DENV1-4) or japanese encephalitis virus (JEV) could be used as antigens for specific serological diagnosis of flavivirus infections 10, 11 . West Nile virus-specific neutralizing epitopes within the structural domain III of the WNV envelope (E) protein also have been identified 9 . Some flaviviruses, such as Saint Louis encephalitis, Japanese encephalitis, dengue and yellow fever, are antigenically related to WNV, and their co-circulation in the same areas has complicated a virus-specific diagnosis of infections in humans and other vertebrate hosts 12 . Therefore, a specific antigen to overcome cross-reaction would be a useful tool in the diagnosis. We show here the production and the preliminary serological tests of a recombinant, bacterially expressed, DIII (r-DIII) peptide from the E protein of WNV.
Inactivated WNV (strain NY-99) was provided by Dr. Mike Drebot (Public Health Agency of Canada, Canadian Science Center). Viral RNA was extracted with QIAamp Extraction kit (QIAGEN, Germany), according to the manufacturer's instructions. DIII was amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) with the following primers (nucleotide positions 1813-2203, GeneBank accession noDQ211652.1): WNV1-forward (GGATCCGTCGGGTCATTTGAAGTGTAGA) and WNV2-reverse (AAGCTTGAGGGTGGTTGTAAAGGCTTTG). Restriction sites for Bam HI and Hind III were included in the primer sequence (bold). Briefly, cDNA was generated using the SuperScriptFirst-Strand Synthesis System for RT-PCR www.scielo.br/rsbmt Chávez JH et al -West Nile domain III antigens for serological diagnosis according to the manufacturer's protocol (Invitrogen, USA). cDNA was used as a template to amplify DIII by PCR using WNV1 and WNV2 primers and Platinum® Taq High Fidelity (Invitrogen, USA). The amplified PCR product was purified from agarose gel with QIAquick Gel Extraction Kit (QIAGEN, Germany) and cloned into the pCR2.1. Topo TA Cloning kit (Invitrogen, USA). Purified pCR2.1 plasmids containing the DIII were sequenced and analyzed. Subsequently, pCR2.1 plasmids and the expression vector PQE31 (QIAGEN, USA) were submitted to a double digestion by Bam HI and Hind III enzymes (Invitrogen, USA) for 4h. The insert and the expression vector PQE31 were ligated by T4 ligase (Fermentas, USA) during 16h at 14 o C and used to transform M15 Escherichia coli strain cells. Sequence analyses of DIII in the expression vector were performed for further expression of the peptide.
Expression was carried out according to QIA express kit (QIAGEN, USA). Escherichia coli M15 cells were cultured with Luria-Bertani medium containing 100µg/mL of ampicillin and 25µg/mL of kanamycin. Protein expression was induced with 1mM of IPTG at 37 o C for 4h. The cells were then harvested and resuspended in lysis buffer (NaH 2 PO 4 100mM, Tris-HCL 10mM, and urea 8M, pH 8). A protein with approximately 15kd after IPTG induction (Figure 1 ) was observed. Purification was performed with the clarified cell extract mixed with 50% nickel-nitrilotriacetic acid (Ni-NTA) agarose (QIAGEN, USA) for 2h on ice. This mixture was used to load a propylene column washed extensively with wash buffer (NaH 2 PO 4 100mM, Tris-HCl 10mM, and urea 8M, pH 6.3) and with elution buffer (NaH 2 PO 4 100mM, Tris-HCL 10mM, and urea 8M, pH 4.5). Protein purity was assessed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 12% acrylamide gels (Figure 1 ). Gels were stained with Coomassie brilliant blue R-250, and the protein content was determined using the reducing agent detergent compatible (RCDC) assay (Bio-Rad, USA) using bovine serum albumin as standard. Protein was characterized using mass spectroscopy (Maldi-TOF-TOF) (data not shown) and by immunoblotting using a human monoclonal immunoglobulin (Ig) M antibody for WNV (Pan-Bio, Australia) (Figure 2) . Oropouche virus (OROV) and Mayaro virus (MAYV) were used as primary antibody negative controls. Considering that linear epitopes in rDIII of flavivirus could bind to antibodies and even promote virus neutralization, the purified denatured rDIII-WNV peptide was used as antigen in an ELISA 13 . Denatured rDIII WNV was used because of the large amount expressed and high purification level. It was observed that the MIAF of SLEV reacted strongly against rDIII-WNV in the test, whereas MIAFs of ROCV and CPCV did not react, although they also are related to WNV. The strong reaction of SLEV MIAF with rDIII-WNV could be explained by the close phylogenetic relationship between these two viruses compared with the other Brazilian flaviviruses ROCV and CPCV 14, 15 . MIAFs of viruses belonging to other viral families, such as OROV (Bunyaviridae) and MAYV (Alphaviridae), also did not react in the recombinant ELISA. A reactivity panel of the tested MIAFs against rDIII-WNV ELISA is shown in Table 1 . Unfortunately, it was not possible to test a WNV MIAF in this ELISA because of the lack of this virus in Brazil and, consequently, the restriction in MIAF production. Nonetheless, even considering rDIII-WNV as a suitable antigen in the ELISA, based on the cross-reaction with SLEV MIAF, further investigations might be performed to better establish its utility in this test. A panel of WNV-positive and WNV-negative human and other vertebrate's sera should be used to evaluate the efficacy of this WNV-ELISA. In addition, it would be important to perform a comparison of this standardized ELISA with commercially available tests to assure sensibility and specificity. In short, we have produced an rDIII-WNV antigen that may be useful as antigen in serologic diagnosis of WNV infections. Obviously, further tests must be performed to better characterize this antigen, such as true determination of specificity and sensibility against positive and negative WNV sera. Although those preliminary results strongly indicate that the produced antigen may be used as a national diagnosis resource, in case of the introduction of WNV in Brazil, minimizing the use of expensive imported serologic assays.
